e-learning
resources
Munich 2006
Tuesday 05.09.2006
Contemporary issues in thoracic surgical oncology
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Toxicity in isolated lung perfusion with melphalan for resectable lung metastases
M. J. J. H. Grootenboers, J. M. Hendriks, W. J. van Boven, C. A. J. Knibbe, P. E. Van Schil, F. M. Schramel (Nieuwegein, Netherlands; Edegem, Belgium)
Source:
Annual Congress 2006 - Contemporary issues in thoracic surgical oncology
Session:
Contemporary issues in thoracic surgical oncology
Session type:
Oral Presentation
Number:
4387
Disease area:
Thoracic oncology
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. J. J. H. Grootenboers, J. M. Hendriks, W. J. van Boven, C. A. J. Knibbe, P. E. Van Schil, F. M. Schramel (Nieuwegein, Netherlands; Edegem, Belgium). Toxicity in isolated lung perfusion with melphalan for resectable lung metastases. Eur Respir J 2006; 28: Suppl. 50, 4387
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: ICU admission of lung cancer patients – Is COVID-19 a game-changer?
Surgical vs non-surgical treatment of early stage non-small cell lung cancer: here's the fight
N3 hilar sampling decision in the staging of mediastinal lung cancer
Related content which might interest you:
Isolated lung perfusion with melphalan for resectable lung metastases: a phase I clinical trial
Source: Eur Respir J 2004; 24: Suppl. 48, 42s
Year: 2004
Combination chemotherapy with gemcitabine using isolated lung perfusion for the treatment of lung metastases
Source: Eur Respir J 2004; 24: Suppl. 48, 42s
Year: 2004
Temozolomide in the treatment of brain metastases in lung cancer patients
Source: Eur Respir J 2003; 22: Suppl. 45, 65s
Year: 2003
Salvage lung resection for local recurrence after stereotactic body radiotherapy for primary and metastatic lung cancers
Source: Annual Congress 2011 - General thoracic surgery I
Year: 2011
Brain metastases in lung cancer patients
Source: International Congress 2019 – ME4 Brain metastases in lung cancer patients.
Year: 2019
Early complications after lung resections at patients treated for lung cancer with and without neoadjuvant hemiotheraphy
Source: Annual Congress 2011 - Instructive clinical aspects of lung cancer
Year: 2011
Whole brain re-irradiation in lung cancer patients with multiple brain metastases
Source: Annual Congress 2010 - Treatment of lung cancer
Year: 2010
The estimations of two regimenes of radiation of brain metastases in patients with primary lung cancer
Source: Annual Congress 2007 - Therapy of thoracic malignancies
Year: 2007
Characteristics of radiation pneumonitis and lung function after curatively intended radiotherapy in non-small cell lung carcinoma
Source: International Congress 2018 – Lung cancer: modern therapies and beyond
Year: 2018
Palliative radiotherapy for brain- only metastases of non small cell lung cancer
Source: Annual Congress 2008 - Diagnostic and therapeutic problems in thoracic surgery
Year: 2008
Initial combined intratumoral chemotherapy with cisplatin and irradiation for inoperable non-small cell obstructive lung cancer
Source: Eur Respir J 2004; 24: Suppl. 48, 492s
Year: 2004
Extrathoracic 18-FDG-PET uptakes in non small cell lung cancer (NSCLC) preoperative staging
Source: Eur Respir J 2007; 30: Suppl. 51, 430s
Year: 2007
Asymptomatic brain metastases in lung cancer patients
Source: Annual Congress 2008 - Diagnostic aspects in thoracic oncology
Year: 2008
Management of brain metastases in patients with non-small cell lung cancer
Source: International Congress 2017 – Lung cancer - clinical research: scientific pearls from the bedside
Year: 2017
Detecting extrathoracic metastases in patients with non-small cell lung cancer
Source: Eur Respir J 2006; 28: Suppl. 50, 41s
Year: 2006
Survival of lung cancer patients with bone metastases
Source: Annual Congress 2011 - Palliation and morbidity in lung cancer patients
Year: 2011
Whole brain radiotherapy for brain – only metastases of small cell lung cancer
Source: Eur Respir J 2006; 28: Suppl. 50, 755s
Year: 2006
A study on chemotherapy induced interstitial lung disease in patients with unresectable non-small cell lung cancer complicated by combined pulmonary fibrosis and emphysema
Source: Annual Congress 2012 - Treatment of lung cancer
Year: 2012
Fitness before lung resection in lung cancer patients
Source: CME Online 2010
Year: 2010
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept